Skip to content
Open access

Clinical, immunological, and radiological characteristics of pulmonary involvement in childhood-onset primary Sjögren’s syndrome: a single-center retrospective study

Oct 2026 · Frontiers in Immunology · 0 citations · 38 references

Abstract

To describe pulmonary involvement in childhood-onset primary Sjögren’s syndrome (cSS). This retrospective study included 17 children with cSS diagnosed at Jiangxi Provincial Children’s Hospital between August 2021 and August 2025. Patients were classified by baseline chest high-resolution computed tomography (HRCT)as normal CT (n=8) or abnormal CT (n=9); among patients with abnormal CT, 5 had interstitial lung involvement. Clinical, laboratory, radiological, and outcome data were compared. Among 17 children, 14 were female (82.4%), and the mean age at onset was 10.83 ± 3.12 years. Abnormal chest CT findings were detected in 9 patients (52.9%). Age at onset was younger in the abnormal CT group than in the normal CT group (9.37 ± 2.67 vs. 12.48 ± 2.88 years, P = 0.036), and was lowest in the interstitial lung involvement subgroup (8.30 ± 2.51 years, P = 0.022). This subgroup had higher total T and CD4+ T lymphocyte proportions and a lower B lymphocyte proportion P = 0.026, 0.027, and 0.023, respectively. Pleural thickening was the most common CT abnormality (77.8%), followed by ground-glass opacities and nodules >3 mm (33.3% each). Among the 5 patients with interstitial lung involvement, 3 met radiological criteria for ILD, comprising 2 with organizing pneumonia and 1 with nonspecific interstitial pneumonia. During follow-up, 3 of 7 patients with longitudinal imaging achieved complete radiological normalization, 2 improved, and 2 remained stable. Pulmonary abnormalities were common in children with cSS. Younger onset and aberrant T/B lymphocyte subsets showed exploratory associations with pulmonary involvement, which appeared mainly inflammatory and demonstrated favorable radiological evolution during follow-up.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.